Diagram of the mechanism by which PFAS causes a decrease in constipation. by Yifan Zhao (659636)

The expression of miR-122 is decreased as liver fibrosis progressed. by Young Chang (3666829)

Subjects:

Significant interaction (time by group) for PPTd. by Einat Kodesh (13132997)

Capsaicin, pyridoxine, vincristine sulfate and ionomycin significantly decreased axon length ratio but only pyridoxine had no impact on neurotoxicity. by Fei San Lee (17282886)

“…(<b>C</b>) Pyr at 500 μM significantly decreased axon length ratio over time and was significantly lower than PBS control by day 3. …”

Shear stress-strain responses of the reticulocyte membrane at decreased connectivity of the cytoskeleton. by He Li (176971)

Significant associations in GWAS. by Dai Nogimura (21445649)

Subjects:

Decrease in vRNA in brain during antiretroviral therapy. by Sonny R. Elizaldi (9684796)

FASN Expression in OA and RA–shows that FASN is also significantly downregulated in the disease groups for OA and RA, suggesting its decreased activity might influence disease mech... by Chang-sheng Liao (18591969)

Taxa in the gut microbiome differing significantly between CKD patients with and without <i>S</i>. <i>stercoralis</i>. by Nguyen Thi Hai (12700147)

Subjects:

eQTL analysis of significant SNPs. by Dai Nogimura (21445649)

Subjects:

MS decreases the larger amplitude distribution in adult rats. by Jesús David Ayala-Rodríguez (17364296)

(Related to Fig 6): NPF in LNd and NPFR in LPN are not required to high-temperature-induced evening sleep decrease. by Xin Yuan (174619)

Clinical significance of CD133 expression in primary colon cancer tissues. by Takeshi Kaida (6532907)

Representative CEUS images with BR55 of mice with a subcutaneous tumour allograft (arrows) under treatment. by Felix L. Herr (21544362)

Subjects:

Column charts of SI_8min and SI_10min in the therapy and control group at follow-up. by Felix L. Herr (21544362)

Subjects:

Representative immunohistochemical stainings. by Felix L. Herr (21544362)

Subjects:

Experimental design. by Felix L. Herr (21544362)

Subjects:

ROI selection. by Felix L. Herr (21544362)

Subjects:

Column charts of WiAUC in therapy and control group at baseline and follow-up. by Felix L. Herr (21544362)

Subjects:

B2 decreases glycolytic intermediates in cells. by Craig Eyster (392633)

“…<b>(B)</b> Early glycolytic intermediates and the ratio of F-6-P to F-1,6-BP (<i>lower right</i>) are shown. <b>(C)</b> Heatmap of targeted metabolomic data. …”